H. Andreyev

发表

Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.

D. Dearnaley, V. Khoo, D. Tait, 2012, European journal of cancer.

A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy

D. Dearnaley, V. Khoo, K. Harrington, 2005, British Journal of Cancer.

Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial

J. Yarnold, L. Gothard, M. Glover, 2016, The Lancet. Oncology.

Management of intestinal complications in patients with pelvic radiation disease.

L. Fuccio, A. Guido, H. Andreyev, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice

J. Walters, H. Andreyev, R. Arasaradnam, 2019, Frontline Gastroenterology.

What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?

H. Andreyev, D. Fernandes, Dennis Poon, 2018, Frontline Gastroenterology.

The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption – outcomes in patients previously treated for cancer

A. Jackson, A. Lalji, H. Andreyev, 2017, Clinical medicine.

Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome?

A. Lalji, H. Andreyev, C. Shaw, 2015, Clinical medicine.

Outcomes from treating bile acid malabsorption using a multidisciplinary approach

Ankur Gupta, A. Lalji, K. Thomas, 2015, Supportive Care in Cancer.

Are bile acid malabsorption and bile acid diarrhoea important causes of loose stool complicating cancer therapy?

A. Lalji, H. Andreyev, F. Phillips, 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition.

D. Dearnaley, A. Sohaib, B. Benton, 2012, International journal of radiation oncology, biology, physics.

Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

D. Dearnaley, J. Marchesi, Jia V. Li, 2019, Clinical Cancer Research.

Letter in response to Dearnaley et al. letter regarding paper: Evaluating the efficacy of statins and angiotensin converting enzyme-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies.

V. Khoo, D. Tait, L. Wedlake, 2013, European journal of cancer.

Guide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer

A. Davies, H. Andreyev, C. Shaw, 2016, Frontline Gastroenterology.

Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.

H. J. Schneider, A. Norman, D. Cunningham, 1997, British Journal of Cancer.

Nutritional status, the development and persistence of malnutrition and dietary intake in oesophago‐gastric cancer: a longitudinal cohort study

K. Whelan, A. Lalji, H. Andreyev, 2018, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Pelvic radiation disease

H. Andreyev, 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma

D. Cunningham, P. Clarke, P. Ross, 2001, Gut.

The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?

C. Marshall, A. Lalji, H. Andreyev, 2016, Clinical medicine.

Predicting late effects of pelvic radiotherapy: is there a better approach?

V. Khoo, D. Tait, L. Wedlake, 2010, International journal of radiation oncology, biology, physics.

Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy?

V. Khoo, K. Harrington, A. Norman, 2006, Clinical nutrition.

A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.

V. Khoo, K. Harrington, A. Norman, 2006, International journal of radiation oncology, biology, physics.

Topical phenylephrine in the treatment of radiation-induced faecal incontinence.

H. Andreyev, S. Badvie, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Faecal incontinence: A late side-effect of pelvic radiotherapy.

H. Andreyev, S. Putta, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy

G. Frost, H. Andreyev, C. Baldwin, 2004, British Journal of Cancer.

How patients manage gastrointestinal symptoms after pelvic radiotherapy

D. Dearnaley, K. Harrington, A. Norman, 2003, Alimentary pharmacology & therapeutics.

Failure of dietetic referral in patients with gastrointestinal cancer and weight loss.

A. Norman, D. Cunningham, G. Frost, 2006, European journal of cancer.

Late onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists

D. Peel, R. Swindell, H. Andreyev, 2011, Gut.

Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?

J. Lindsay, B. Benton, H. Andreyev, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.

C. Anagnostopoulos, L. Wedlake, A. Lalji, 2009, Clinical therapeutics.

Parenteral nutrition in adult intensive care.

A. Forbes, H. Andreyev, 1993, Postgraduate medical journal.

Manipulating the consequential effect: an alternative approach to reducing pelvic radiation disease other than dose reduction.

L. Wedlake, H. Andreyev, 2011, Current opinion in supportive and palliative care.

A physiological approach to modernize the management of cancer chemotherapy-induced gastrointestinal toxicity

H. Andreyev, 2010, Current opinion in supportive and palliative care.

Systematic review for non-surgical interventions for the management of late radiation proctitis

H. Andreyev, A. Denton, E. Maher, 2002, British Journal of Cancer.

Systematic Review and Meta-Analysis: What is the Prevalence of Non-Malignant, Organic Gastrointestinal Disorders Misdiagnosed as Lrritable Bowel Syndrome?

G. Major, H. Andreyev, Graham R Law, 2021 .

“Pelvic radiation disease”: New understanding and new solutions for a new disease in the era of cancer survivorship

A. Wotherspoon, M. Hauer-Jensen, J. Denham, 2011, Scandinavian journal of gastroenterology.

Defining pelvic-radiation disease for the survivorship era.

A. Wotherspoon, M. Hauer-Jensen, J. Denham, 2010, The Lancet. Oncology.

A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences

A. Hart, H. Andreyev, C. Norton, 2020, Supportive Care in Cancer.

Persistence and development of malnutrition in patients with upper-gastrointestinal cancer: a longitudinal cohort study

K. Whelan, H. Andreyev, C. Shaw, 2015, Proceedings of the Nutrition Society.

Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial.

A. Norman, D. Cunningham, M. O'Brien, 2011, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Response to nutrition support, quality of life and clinical outcomes

H. Andreyev, C. Baldwin, A. Spiro, 2012 .

Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation

A. Norman, D. Cunningham, U. Khalid, 2006, Supportive Care in Cancer.

Bowel dysfunction in survivors of gynaecologic malignancies

H. Andreyev, Y. Ribas, M. Bonet, 2020, Supportive Care in Cancer.

Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study.

V. Khoo, K. Whelan, K. Harrington, 2006, Clinical nutrition.

Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials

K. Whelan, L. Wedlake, H. Andreyev, 2014, Inflammatory bowel diseases.

Clinical trial: Efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies.

D. Dearnaley, V. Khoo, D. Tait, 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists

R. Swindell, A. Lalji, H. Andreyev, 2012, Supportive Care in Cancer.

Micrometastases: are they clinically significant disease?

D. Cunningham, H. Andreyev, 1997, Gut.

Commentary Micrometastases : are they clinically significant disease ?

H. Andreyev, D. Cunningham, 2022 .

The utility of hyperbaric oxygen therapy to treat recurrent acute bowel obstruction after previous pelvic radiotherapy: a case series

H. Andreyev, M. Abu-Asi, 2013, Supportive Care in Cancer.

Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists

H. Andreyev, C. Shaw, A. Muls, 2012, Frontline Gastroenterology.

Self‐expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass

J. Lindsay, H. Andreyev, P. Vlavianos, 2004, Alimentary pharmacology & therapeutics.

Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment.

Mohid S. Khan, G. Morgan, F. Davies, 2014, Blood.

A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome

G. Major, H. Andreyev, Dennis Poon, 2022, Scientific Reports.

Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli.

A. Forbes, M. Kamm, H. Andreyev, 1996, Journal of clinical gastroenterology.

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

W. Allum, J. Andreyev, H. Andreyev, 2011, Gut.

Association between Meckel's diverticulum and Crohn's disease: a retrospective review.

A. Forbes, H. Andreyev, R. A. Owen, 1994, Gut.

The views and practice of oncologists towards nutritional support in patients receiving chemotherapy

H. Andreyev, C. Baldwin, A. Spiro, 2006, British Journal of Cancer.

Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors.

A. Norman, S. Badve, M. Nicolson, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What is the significance of a faecal elastase-1 level between 200 and 500μg/g?

H. Andreyev, A. Mathew, D. Fernandes, 2023, Frontline Gastroenterology.

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

이석호, 황수찬, T. Walsh, 2001, British Journal of Cancer.

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

A. Norman, D. Cunningham, H. Andreyev, 1998, European journal of cancer.

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

A. Norman, D. Cunningham, P. Clarke, 1998, Journal of the National Cancer Institute.

Radiation enteropathy—pathogenesis, treatment and prevention

M. Hauer-Jensen, J. Denham, H. Andreyev, 2014, Nature Reviews Gastroenterology &Hepatology.

K-ras mutations in patients with early colorectal cancers

A. Norman, D. Cunningham, P. Clarke, 1997, Gut.

Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis.

R. Scholten, J. Vlayen, H. Andreyev, 2016, The Cochrane database of systematic reviews.

Letter in Reply to Professor Bozzetti's letter

H. Andreyev, C. McGough, 2006 .

Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy

K. Whelan, L. Wedlake, H. Andreyev, 2013, Alimentary pharmacology & therapeutics.

Mutant K-ras2 in serum

A. Norman, B. Iacopetta, D. Cunningham, 2003, Gut.

Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides.

P. Workman, D. Cunningham, P. Clarke, 2001, Molecular cancer therapeutics.

Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?

D. Dearnaley, A. Norman, D. Tait, 2005, International journal of radiation oncology, biology, physics.

Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist.

D. Dearnaley, H. Andreyev, A. Muls, 2014, The Lancet. Oncology.

Applicability of the reported prevalence of bile salt malabsorption in irritable bowel: authors' reply

L. Wedlake, H. Andreyev, J. Walters, 2010 .

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndrome

R. A’Hern, L. Wedlake, K. Thomas, 2009, Alimentary pharmacology & therapeutics.

Acid secretion from a Meckel's diverticulum: the unsuspected mimic of Crohn's disease?

A. Forbes, H. Andreyev, R. A. Owen, 1994, The American journal of gastroenterology.

Review article: small intestinal bacterial overgrowth – prevalence, clinical features, current and developing diagnostic tests, and treatment

K. Whelan, H. Andreyev, C. Shaw, 2013, Alimentary pharmacology & therapeutics.

Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy

V. Khoo, K. Harrington, A. Norman, 2008, Alimentary pharmacology & therapeutics.

The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy

I. Chau, L. Wedlake, A. Lalji, 2020, Supportive Care in Cancer.

Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67

H. Andreyev, S. Badvie, T. Allen‐Mersh, 2008, Journal of Clinical Pathology.

Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).

A. Padhani, A. Norman, D. Cunningham, 1995, European journal of cancer.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

S. Burden, T. Lawrie, L. Wedlake, 2018, The Cochrane database of systematic reviews.

SELLING SYRINGES TO DRUG ADDICTS

H. Andreyev, 1985, The Lancet.

GI Consequences of Cancer Treatment: A Clinical Perspective

H. Andreyev, 2016, Radiation Research.

Can biological markers act as non‐invasive, sensitive indicators of radiation‐induced effects in the gastrointestinal mucosa?

D. Dearnaley, V. Khoo, K. Harrington, 2008, Alimentary pharmacology & therapeutics.

Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future.

H. Andreyev, H. Andreyev, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease

J. Lindsay, H. Andreyev, C. Shaw, 2014, Frontline Gastroenterology.

The palatability of milk-based and non-milk-based nutritional supplements in gastrointestinal cancer and the effect of chemotherapy.

A. Norman, D. Cunningham, G. Frost, 2005, Clinical nutrition.

Is weight change an appropriate marker of nutritional intervention in patients with cancer?

P. Milligan, D. Cunningham, H. Andreyev, 2009, Proceedings of the Nutrition Society.

Clinical decision‐making in managing changes in gastrointestinal function following cancer therapies: Is experience enough?

H. Andreyev, A. Muls, K. Klímová, 2018, European journal of cancer care.

Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.

L. Wedlake, K. Thomas, H. Andreyev, 2008, European journal of cancer.

The role of radiological imaging in the patient with gastrointestinal symptoms after pelvic radiotherapy

H. Andreyev, A. Shonde, 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.

Radiation enteropathy - pathogenesis, treatment and prevention | NOVA. The University of Newcastle's Digital Repository

M. Hauer-Jensen, J. Denham, H. Andreyev, 2014 .

Systematic review: the effect of right hemicolectomy for cancer on postoperative bowel function

J. Reilly, H. Andreyev, J. Lund, 2020, Supportive Care in Cancer.

Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial

K. Pennert, H. Gage, J. Lindsay, 2013, The Lancet.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy

S. Burden, T. Lawrie, H. Andreyev, 2017 .

Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injury.

A. Norman, U. Khalid, H. Andreyev, 2007, European journal of cancer care.

Title is sensationalist and inaccurate

H. Andreyev, 1995 .

Parenteral nutrition inadult intensive care

H. Andreyev, 1993 .

A “field change” of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma

H. Andreyev, S. Badvie, T. Allen‐Mersh, 2006, Journal of Clinical Pathology.

The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy

H. Andreyev, C. Gillespie, C. Hackett, 2007, Alimentary pharmacology & therapeutics.

Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)

H. Gage, Jake Jordan, B. Benton, 2017, ClinicoEconomics and outcomes research : CEOR.

Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.

K. Whelan, D. Tait, H. Gage, 2017, The American journal of clinical nutrition.

Nivolumab-induced exocrine pancreatic insufficiency

H. Andreyev, W. Ali, K. Rodgers, 2021, Frontline Gastroenterology.

The significance of rectal bleeding after pelvic radiotherapy

D. Dearnaley, D. Tait, P. Blake, 2005, Alimentary pharmacology & therapeutics.

Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: considerations for future studies.

A. Henderson, D. Dearnaley, R. Stephens, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Argon plasma coagulation in chronic radiation proctitis: Postgate et al.

H. Andreyev, 2007, Endoscopy.

Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?

H. Andreyev, D. Fernandes, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

The political economy of healthcare; a clinical perspective

H. Andreyev, 2006, Gut.

Nutritional and clinical characteristics of patients with gastrointestinal tract (GI) cancers at presentation

D. Cunningham, K. Thomas, H. Andreyev, 2009, Proceedings of the Nutrition Society.

The NUT study: what effect does nutritional intervention have on energy intake in patients with gastrointestinal cancer receiving chemotherapy?

K. Whelan, H. Andreyev, C. Baldwin, 2008, Proceedings of the Nutrition Society.

The NUT study: the effect of dietetic and oral nutritional interventions on survival and quality of life in patients with weight loss undergoing palliative chemotherapy for gastrointestinal (GI) or lung malignancy, a randomised controlled trial

A. Norman, D. Cunningham, H. Andreyev, 2008, Proceedings of the Nutrition Society.